Because we are confronted with the increasing use of tigecycline for the treatment of infections due to multidrug-resistant bacteria, it is important to note that two recent meta-analyses raise concerns about the efficacy and safety of therapy with this antibiotic. A higher overall mortality and a higher incidence of adverse effects, especially nausea and vomiting, have been observed with tigecycline compared with other regimens.1,2 Tigecycline-induced acute pancreatitis is considered an uncommon event, with an estimated incidence between 1% and 1‰. The mechanism remains unknown.3 Five cases of interstitial or oedematous pancreatitis have been reported, all of which occurred during the second week of therapy in patients without other risk factors for pancreatitis. None of the patients required intensive care.3,4 To our knowledge, we report on the first case of acute necrotizing pancreatitis related to tigecycline.

Acute necrotizing pancreatitis related to tigecycline

PAPA, GIOVANNI;ARNEZ, ZORAN MARIJ;LUZZATI, ROBERTO
2012-01-01

Abstract

Because we are confronted with the increasing use of tigecycline for the treatment of infections due to multidrug-resistant bacteria, it is important to note that two recent meta-analyses raise concerns about the efficacy and safety of therapy with this antibiotic. A higher overall mortality and a higher incidence of adverse effects, especially nausea and vomiting, have been observed with tigecycline compared with other regimens.1,2 Tigecycline-induced acute pancreatitis is considered an uncommon event, with an estimated incidence between 1% and 1‰. The mechanism remains unknown.3 Five cases of interstitial or oedematous pancreatitis have been reported, all of which occurred during the second week of therapy in patients without other risk factors for pancreatitis. None of the patients required intensive care.3,4 To our knowledge, we report on the first case of acute necrotizing pancreatitis related to tigecycline.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2627645
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 7
social impact